Financial statements Nts Pharma
Balance sheet data of NTS PHARMA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 687 666,04 | 313 738,29 | 337 140,76 | 929 579,79 | 996 395,95 |
| A. Fixed assets | 108 751,53 | 78 900,34 | 56 778,23 | 395 591,53 | 23 541,20 |
| B. Current assets | 578 914,51 | 234 837,95 | 280 362,53 | 533 988,26 | 972 854,75 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 687 666,04 | 313 738,29 | 337 140,76 | 929 579,79 | 996 395,95 |
| A. Equity | 179 674,80 | -34 927,37 | 153 508,65 | 157 186,10 | 86 923,18 |
| B. Liabilities and provisions for liabilities | 507 991,24 | 348 665,66 | 183 632,11 | 772 393,69 | 909 472,77 |
| I. Long-term liabilities | 225 032,56 | 20 000,00 | 0,00 | 290 164,94 | 421 979,30 |
| II. Short-term liabilities | 282 958,68 | 328 665,66 | 183 632,11 | 482 228,75 | 487 493,47 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.